glp-1 receptor agonist nephrolithiasis Agonists in Chronic Kidney Disease Frontiers | GLP-1 Receptor Agonists
Description
however, trials developed mainly to evaluate the long-term impact of tirzepatide on cardiovascular events, including stroke, are currently in progress [42]
References 1 MalikVSWilletWCHuFB
FDA-approved alternatives cost $10-$200 monthly compared to GLP-1 prices
doi: 10.1056/NEJMoa2404881
The most frequent adverse events associated with resmetirom were diarrhea and nausea
The individual agents differ in their unique pharmacology such as half-life and degree of structural homology to GLP-1 [39]
